NCT04097821 Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients Status TERMINATED Phase PHASE1/PHASE2
NCT04097379 Safety, Tolerability and Preliminary Efficacy of Multiple Intra-articular Injections of LRX712 in Patients With Knee OA Status COMPLETED Phase PHASE2
NCT04084314 Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study Status COMPLETED Phase PHASE4
NCT04081701 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. Status RECRUITING Phase PHASE4
NCT04079231 Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema Status WITHDRAWN Phase PHASE3
NCT04074590 Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis Status TERMINATED Phase PHASE2
NCT04072887 Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients Status COMPLETED Phase PHASE2
NCT04072302 Safety and Causal Prophylactic Efficacy of KAF156 in a Controlled Human Malaria Challenge Model Status COMPLETED Phase PHASE1
NCT04066244 Study of Safety and Proof of the Mechanism of BLZ945 in ALS Patients Status TERMINATED Phase PHASE2
NCT04065841 Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis. Status TERMINATED Phase PHASE2
NCT04064242 Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis Status COMPLETED Phase PHASE2
NCT04058756 Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04058067 To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema Status COMPLETED Phase PHASE3
NCT04053764 Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT04047472 Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration Status COMPLETED Phase PHASE3
NCT04037176 Behandling af Boern Med Foedevareallergi Med Omalizumab (Xolair) Status COMPLETED Phase PHASE4
NCT04035668 A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome Status TERMINATED Phase PHASE2
NCT04023552 Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD Status ACTIVE_NOT_RECRUITING Phase PHASE3